Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Sale of product	$ 12,267,385	$ 11,181,988
Cost of product	4,888,409	4,891,927
Gross profit	7,378,976	6,290,061
Operating costs and expenses:
Salaries and contract labor	4,032,155	3,390,652
General, administrative and consulting	3,545,766	3,568,590
Research and development	577,354	533,716
Total operating expenses	8,155,275	7,492,958
Operating loss	(776,299)	(1,202,897)
Other income (expense):
Other income	160,173	2,110,576
Interest income	78,890	9,502
Interest expense	(331,780)	(613,943)
Total other (expense) income	(92,717)	1,506,135
Net income (loss)	$ (869,016)	$ 303,238
Net income per common share - basic: (in dollars per share)	$ 0	$ 0
Net income per common share - diluted: (in dollars per share)	$ 0	$ 0
Weighted average common shares outstanding - basic (in shares)	517,777,847	510,794,145
Weighted average common shares outstanding - diluted (in shares)	517,777,847	510,794,145